A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).

Name: A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
Author: Mayer, Ingrid A

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB). — المؤلف: Mayer, Ingrid A — Clinical cancer research : an official journal of the American Association for Cancer Research 20200706

المؤلف: Mayer, Ingrid A
النشر: Clinical cancer research : an official journal of the American Association for Cancer Research 20200706
الوصف: 2975-2987 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Combined Chemotherapy Protocols؛ Biomarkers, Tumor؛ Breast Neoplasms؛ Cell Proliferation؛ Class I Phosphatidylinositol 3-Kinases